Trial intelligence / Profile preview

Multicenter Randomized Double-Blind Placebo-Controlled Phase IIb/III Trial of Jointstem in Degenerative Knee Osteoarthritis

KCT0001619Phase 3Active, not recruiting

Sponsor
R Bio
Start
Aug 2015
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Jointstem with Placebo (2 arms). Started Aug 2015; status: active, not recruiting.

02

Drugs

JOINTSTEM
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on KCT0001619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call